Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials.
Thomas KaragiannisKonstantinos MalandrisIoannis AvgerinosAthina StamatiPanagiota KakotrichiAris LiakosDespoina VasilakouNikolaos KakaletsisApostolos TsapasApostolos TsapasPublished in: Diabetologia (2024)
PROSPERO registration no. CRD42022382594.
Keyphrases